1-(3-Bromo-5-fluoropyridin-2-yl)ethanone, 97%, 100mg

sec-Butyl Ether (DL- and meso- mixture) (stabilized with HQ)>97.0%(GC)25mL

5-(2,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

(R)-1-N-Boc-4-N-Boc-Piperazine-2-carboxylic acid, 95.0%, 5g

8-Methyl-2,8-diazaspiro[4.5]decane dihydrochloride, 98%, 250mg

2-(4-Fluorophenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole, 97%, 250mg

Ethyl 2-(6-methylpyridin-3-yl)acetate, 97%, 5g

6-Methoxy-2-oxo-1,2,3,4-tetrahydroquiniline, 98.0%, 10g

L-Aspartic acid, 500 g

1H-Pyrazole-3,5-diamine, 95.0%, 100mg

N,N'-(R)-[1,1'-Binaphthalene]-2,2'-diylbis[N'-[3,5-bis(trifluoromethyl)phenyl]thiourea], 97%, 250mg

3-METHOXY-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOQUINOLINE, 95.0%, 250mg

(R)-3-Methylpyrrolidin-2-one, 98+%, 250mg